Literature DB >> 24432133

Alternative synthetic tools to phospho-specific antibodies for phosphoproteome analysis: progress and prospects.

James I Murray1, Alan C Spivey1, Rudiger Woscholski1.   

Abstract

Signal transduction cascades in living systems are often controlled via post-translational phosphorylation and dephosphorylation of proteins. These processes are catalyzed in vivo by kinase and phosphatase enzymes, which consequently play an important role in many disease states, including cancer and immune system disorders. Current techniques for studying the phosphoproteome (isotopic labeling, chromatographic techniques, and phosphospecific antibodies), although undoubtedly very powerful, have yet to provide a generic tool for phosphoproteomic analysis despite the widespread utility such a technique would have. The use of small molecule organic catalysts that can promote selective phosphate esterification could provide a useful alternative to current state-of-the-art techniques for use in, e.g., the labeling and pull-down of phosphorylated proteins. This report reviews current techniques used for phosphoproteomic analysis and the recent use of small molecule peptide-based catalysts in phosphorylation reactions, indicating possible future applications for this type of catalyst as synthetic alternatives to phosphospecific antibodies for phosphoproteome analysis.

Entities:  

Keywords:  Kinase mimetic; Kinase mimic; Nucleophilic catalysis; Phosphoproteome; Phosphorylation; Phosphospecific antibody

Year:  2013        PMID: 24432133      PMCID: PMC3787206          DOI: 10.1007/s12154-013-0100-y

Source DB:  PubMed          Journal:  J Chem Biol        ISSN: 1864-6158


  38 in total

1.  Discovery of a catalytic asymmetric phosphorylation through selection of a minimal kinase mimic: a concise total synthesis of D-myo-inositol-1-phosphate.

Authors:  B R Sculimbrene; S J Miller
Journal:  J Am Chem Soc       Date:  2001-10-17       Impact factor: 15.419

2.  Metal chelate affinity chromatography, a new approach to protein fractionation.

Authors:  J Porath; J Carlsson; I Olsson; G Belfrage
Journal:  Nature       Date:  1975-12-18       Impact factor: 49.962

Review 3.  The protein kinase complement of the human genome.

Authors:  G Manning; D B Whyte; R Martinez; T Hunter; S Sudarsanam
Journal:  Science       Date:  2002-12-06       Impact factor: 47.728

4.  Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry.

Authors:  Laurence M Brill; Arthur R Salomon; Scott B Ficarro; Mridul Mukherji; Michelle Stettler-Gill; Eric C Peters
Journal:  Anal Chem       Date:  2004-05-15       Impact factor: 6.986

Review 5.  Advances in quantitative phosphoproteomics.

Authors:  Carol L Nilsson
Journal:  Anal Chem       Date:  2011-11-21       Impact factor: 6.986

6.  Antibody-based Proteomics: From bench to bedside.

Authors:  Sophie Dahan; Eric Chevet; Jian-Feng Liu; Michel Dominguez
Journal:  Proteomics Clin Appl       Date:  2007-08-17       Impact factor: 3.494

7.  Unified total syntheses of the inositol polyphosphates: D-I-3,5,6P3, D-I-3,4,5P3, D-I-3,4,6P3, and D-I-3,4,5,6P4 via catalytic enantioselective and site-selective phosphorylation.

Authors:  Adam J Morgan; Shio Komiya; Yingju Xu; Scott J Miller
Journal:  J Org Chem       Date:  2006-09-01       Impact factor: 4.354

Review 8.  Artificial proteolysis by a metal chelate: methodology and mechanism.

Authors:  T M Rana
Journal:  Adv Inorg Biochem       Date:  1994

9.  Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.

Authors:  Jesper V Olsen; Blagoy Blagoev; Florian Gnad; Boris Macek; Chanchal Kumar; Peter Mortensen; Matthias Mann
Journal:  Cell       Date:  2006-11-03       Impact factor: 41.582

10.  Temporal analysis of phosphotyrosine-dependent signaling networks by quantitative proteomics.

Authors:  Blagoy Blagoev; Shao-En Ong; Irina Kratchmarova; Matthias Mann
Journal:  Nat Biotechnol       Date:  2004-08-15       Impact factor: 54.908

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.